Literature DB >> 7993407

Brief report: molecular biology and the early detection of carcinoma of the bladder--the case of Hubert H. Humphrey.

R H Hruban1, P van der Riet, Y S Erozan, D Sidransky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7993407     DOI： 10.1056/NEJM199405053301805

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  Demystified ... p53.

Authors:  S J Darnton
Journal:  Mol Pathol       Date:  1998-10

2.  Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.

Authors:  R H Hruban; P D Sturm; R J Slebos; R E Wilentz; A R Musler; C J Yeo; T A Sohn; M L van Velthuysen; G J Offerhaus
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.

Authors:  Philip Levy Ho; Erica Julianne Lay; Weiguo Jian; Diana Parra; Keith Syson Chan
Journal:  Cancer Res       Date:  2012-04-24       Impact factor: 12.701

4.  The structural basis of molecular genetic deletions. An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma.

Authors:  D J Brat; S A Hahn; C A Griffin; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 5.  Molecular assessment of cancer.

Authors:  C Caldas
Journal:  BMJ       Date:  1998-05-02

6.  Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations.

Authors:  Austin K Mattox; Yuxuan Wang; Simeon Springer; Joshua D Cohen; Srinivasan Yegnasubramanian; William G Nelson; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-17       Impact factor: 11.205

7.  Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.

Authors:  H Bialkowska-Hobrzanska; L Bowles; B Bukala; M G Joseph; R Fletcher; H Razvi
Journal:  Mol Diagn       Date:  2000-12

Review 8.  Screening for cancer with molecular markers: progress comes with potential problems.

Authors:  John A Baron
Journal:  Nat Rev Cancer       Date:  2012-04-12       Impact factor: 60.716

Review 9.  Bladder tumor markers: need, nature and application. 1. Nucleus-based markers.

Authors:  M M Kirollos; S McDermott; R A Bradbrook
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

10.  Microsatellite alterations as clonal markers for the detection of human cancer.

Authors:  L Mao; D J Lee; M S Tockman; Y S Erozan; F Askin; D Sidransky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.